Related Experiment Video
Updated: Aug 9, 2026
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Recent advances in the treatment of oligodendrogliomas
1Princess Margaret Hospital, Department of Medicine, Toronto, ON, Canada.
Abstract:
The optimal treatment for patients with oligodendrogliomas is unknown, and current management strategies remain controversial. This past year, further exploration of the molecular genetics of the tumors and its prognostic implications for outcome, evaluation of the utility of positron emission tomography imaging, and the role of radiation and chemotherapy in the treatment of oligodendrogliomas have been reported. It is becoming increasingly apparent that oligodendrogliomas are several distinct diseases on a molecular level, and that key genetic derangements can signify a response to treatment and favorable outcome. The added contributions of recent publications consolidates these emerging impressions. Ultimately, the combination of improved imaging techniques, molecular profiling, and new therapies should result in improved outcome with reduced treatment-related toxicity for patients with newly diagnosed, progressive, and recurrent oligodendrogliomas.
Insights
Optimal treatment for oligodendrogliomas is unclear. Emerging research shows molecular genetics and advanced imaging can predict treatment response and improve outcomes for these brain tumors.
Area of Science:
- Neuro-oncology
- Molecular Genetics
- Medical Imaging
Background:
- Optimal treatment strategies for oligodendrogliomas remain controversial and undefined.
- Recent research has focused on molecular genetics, positron emission tomography (PET) imaging, and the roles of radiation and chemotherapy.
Purpose of the Study:
- To review recent advancements in understanding oligodendrogliomas.
- To highlight the prognostic implications of molecular genetics.
- To evaluate the utility of advanced imaging techniques and therapeutic roles.
Main Methods:
- Review of recent publications on oligodendroglioma research.
- Analysis of molecular genetic findings and their correlation with patient outcomes.
- Evaluation of positron emission tomography (PET) imaging utility.
- Assessment of radiation and chemotherapy roles in treatment.
Main Results:
- Oligodendrogliomas represent distinct molecular subtypes.
- Specific genetic derangements are indicative of treatment response and favorable prognosis.
- Advancements in imaging and molecular profiling are consolidating these findings.
Conclusions:
- Oligodendrogliomas are heterogeneous diseases at the molecular level.
- Molecular profiling and improved imaging are crucial for personalized treatment strategies.
- Integration of molecular data, imaging, and novel therapies promises improved outcomes and reduced toxicity for patients.
